Sonidegib
1 abstract
Abstract
A phase I trial of sequential dosing of sonidegib and pembrolizumab in advanced solid tumors (aST) and non–small-cell lung cancer (NSCLC).Org: Mayo Clinic, Division of Biomedical Statistics and Informatics, Mayo Clinic Florida, Department of Oncology and Haematology, Division of Oncology, University Hospital of Modena, Modena, Italy, Department of Quantitative Science Research,